Company / Capital Expenditures
OptimizeRx Corp Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$112.0K
FY2025
5-year range
$68.0K / $112.0K
FY2021-FY2025
Trend
+28.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $2,046 in FY2016 to $178,434 in FY2017.
Based on SEC 10-K filings.
$112,000 in FY2025 with a 5-year CAGR of +5.0%.
Improved from $81,005 to $112,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +5.0%, indicating consistent growth.
- In FY2025, capital expenditures increased 28.7% year-over-year.
- Peak capital expenditures was recorded in FY2017.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $112.0K | +28.7% |
| FY2024 | $87.0K | +7.4% |
| FY2023 | $81.0K | -19.3% |
| FY2022 | $100.3K | +47.4% |
| FY2021 | $68.0K | -22.4% |
| FY2020 | $87.7K | +155.3% |
| FY2019 | $34.4K | -18.7% |
| FY2018 | $42.2K | -76.3% |
| FY2017 | $178.4K | +8621.1% |
| FY2016 | $2.0K | -70.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026